Health In Tech Announces $7.0 Million Private Placement

Rhea-AI Summary

Health In Tech (NASDAQ:HIT) announced a private investment in public equity (PIPE) expected to raise approximately $7.0 million before fees by issuing 5,600,000 shares of Class A common stock at $1.25 per share. The PIPE is expected to close on or about March 27, 2026, subject to customary closing conditions.

The company named Craig-Hallum Capital Group LLC as sole placement agent and said net proceeds are intended for sales distribution expansion, technology and product development, general corporate purposes, and working capital. Health In Tech agreed to file a resale registration statement for the issued shares.

AI-generated analysis. Not financial advice.

Positive

• Gross proceeds of $7.0 million expected from PIPE
• Issuance of 5,600,000 shares at $1.25 per share
• Registration rights agreed to enable resale filing

Negative

• Potential shareholder dilution from issuance of 5,600,000 shares
• Gross proceeds reduced by placement agent fees and offering expenses
• Closing is subject to customary conditions, not certain by March 27, 2026

News Market Reaction – HIT

-11.05%

11 alerts

-11.05% News Effect

+2.6% Peak Tracked

-25.3% Trough Tracked

-$14M Valuation Impact

$113.92M Market Cap

0.4x Rel. Volume

On the day this news was published, HIT declined 11.05%, reflecting a significant negative market reaction. Argus tracked a peak move of +2.6% during that session. Argus tracked a trough of -25.3% from its starting point during tracking. Our momentum scanner triggered 11 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $14M from the company's valuation, bringing the market cap to $113.92M at that time.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

PIPE gross proceeds: $7.0 million Shares issued: 5,600,000 shares Offer price: $1.25 per share +5 more

8 metrics

PIPE gross proceeds $7.0 million Expected gross proceeds from private placement before fees

Shares issued 5,600,000 shares Class A common stock to be issued in PIPE

Offer price $1.25 per share Class A common stock price in private placement

2025 revenue $33.3 million Full-year 2025 revenue from 8-K on 2026-03-25

2025 net income $1.28 million Full-year 2025 net income from 8-K

Revenue growth 71% Full-year 2025 revenue growth vs 2024

2026 revenue guidance $45–$50 million Company outlook for 2026 revenue from 8-K

2025 adjusted EBITDA $4.11 million Adjusted EBITDA for 2025 from 8-K

Market Reality Check

Price: $0.9870 Vol: Volume 354,824 is 49% bel...

low vol

$0.9870 Last Close

Volume Volume 354,824 is 49% below 20-day average of 692,172, suggesting a muted pre-news response. low

Technical Trading 6% below 200-day MA of 1.93, after a prior rebound from the 52-week low.

Peers on Argus

HIT is down about 0.6% while close peers are mixed: DUOT, SSTI, SVCO up, EXFY an...

1 Up 1 Down

HIT is down about 0.6% while close peers are mixed: DUOT, SSTI, SVCO up, EXFY and ASUR down. Momentum scanner shows MAPS up and AEYE down, reinforcing a stock-specific reaction rather than a sector-wide move.

Historical Context

5 past events · Latest: 2026-03-17 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
2026-03-17	AI collaboration	Positive	+7.7%	Strategic collaboration with Ciklum to scale AI-driven InsurTech platform on AWS.
2026-03-09	Earnings date set	Neutral	+9.1%	Announcement of Q4 and full-year 2025 results date and conference call details.
2026-02-24	CTO appointment	Positive	+1.7%	Former SAP and IBM executive formally named CTO to lead AI and platform roadmap.
2026-01-13	Growth officer hire	Positive	-3.7%	New Chief Growth Officer appointed to drive revenue and distribution expansion.
2026-01-12	Summit agenda	Neutral	-8.1%	Unveiling agenda for hitDavos 2026 InsurTech summit during WEF week.

Pattern Detected

Recent news has often seen positive or neutral headlines met with mixed reactions, including two notable selloffs on ostensibly neutral/positive updates.

Recent Company History

Over the last few months, HIT reported several growth-focused updates. A Mar 17 AWS-based AI collaboration and a CTO appointment on Feb 24 both saw modest gains. An earnings date announcement on Mar 9 coincided with a stronger +9.14% move. However, leadership and event announcements in January triggered drawdowns of -3.72% and -8.07%. Against this backdrop, today’s private placement adds capital but also dilution alongside a stock already well below its 52-week high.

Market Pulse Summary

The stock dropped -11.1% in the session following this news. A negative reaction despite solid under...

Analysis

The stock dropped -11.1% in the session following this news. A negative reaction despite solid underlying fundamentals fits a pattern where HIT has occasionally sold off on news, as seen with January leadership updates. The private placement adds cash proceeds of $7.0 million but also increases the share count by 5,600,000, which can pressure valuation. With shares already trading well below the 52-week high and below the 200-day moving average, investors may reassess dilution against the company’s recent 71% revenue growth.

Key Terms

private investment in public equity, pipe, securities purchase agreement, regulation d, +3 more

7 terms

private investment in public equity financial

"entered into a securities purchase agreement for a private investment in public equity financing (the "PIPE")"

Private investment in public equity occurs when investors buy shares directly from a company that is publicly traded, often at an early stage or at a discount, instead of purchasing them on the open market. This allows investors to acquire a stake more quickly and with potentially better terms, which can influence the company's future growth and stability—making it an important option for those seeking to support or benefit from a company's development.

pipe financial

"for a private investment in public equity financing (the "PIPE") that is expected"

A "pipe" is a planned series of financial transactions or projects that companies intend to carry out over time, often involving the raising of funds or development of new assets. It matters to investors because it provides a clear picture of a company's future growth plans and potential revenue, helping them assess the company's upcoming opportunities and overall stability. Think of it as a detailed roadmap guiding a company's future steps.

securities purchase agreement financial

"announced that it has entered into a securities purchase agreement for a private"

A securities purchase agreement is a written contract between a buyer and a seller outlining the terms for buying or selling financial assets such as stocks or bonds. It specifies details like the price, quantity, and conditions of the transaction, similar to a shopping list with agreed-upon terms. For investors, it provides clarity and legal protection when transferring ownership of these financial instruments.

regulation d regulatory

"under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Securities Act"), and/or Regulation D promulgated thereunder"

Regulation D is a set of rules that govern how companies can raise money from investors without going through the full process required for public stock offerings. It provides simplified options for private placements, making it easier for companies to seek investments from a smaller group of investors. For investors, it offers opportunities to invest in private companies, often with fewer restrictions, but also with different levels of risk and disclosure.

registration statement regulatory

"may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption"

A registration statement is a formal document that companies file with a government agency to offer new shares of stock to the public. It provides essential information about the company's finances, operations, and risks, helping investors make informed decisions. Think of it as a detailed product description that ensures transparency and trust before buying into a company.

resale registration statement regulatory

"agreed to file a resale registration statement with the Securities and Exchange Commission registering the resale"

A resale registration statement is a document filed with regulators that allows existing shareholders to sell their shares to the public. It provides the necessary legal approval and information for these shares to be resold on the market, helping to increase the availability of shares for trading. For investors, it signals that shares held by current owners can be offered for sale, potentially affecting share prices and market liquidity.

forward-looking statements regulatory

"Use of Forward-Looking StatementsCertain statements in this press release are forward-looking statements for purposes"

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

AI-generated analysis. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

STUART, Fla., March 25, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or the "Company"), an AI-enabled InsurTech platform company, today announced that it has entered into a securities purchase agreement for a private investment in public equity financing (the "PIPE") that is expected to result in gross proceeds of approximately $7.0 million before deducting placement agent fees and offering expenses. The PIPE is expected to close on or about March 27, 2026, subject to the satisfaction of customary closing conditions.

Pursuant to the terms of the securities purchase agreement, at the closing of the PIPE, Health In Tech will issue an aggregate of 5,600,000 shares of Class A common stock at a price of $1.25 per share.

Craig-Hallum Capital Group LLC acted as the sole placement agent for the PIPE.

The Company intends to use the net proceeds from the PIPE to expand sales distribution, advance technology development, support new product development, and for general corporate purposes and working capital.

The securities described above are being offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Securities Act"), and/or Regulation D promulgated thereunder, and have not been registered under the Securities Act or applicable state securities laws. Accordingly, the securities issued in the PIPE may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws. Pursuant to a registration rights agreement with the PIPE investors, the Company has agreed to file a resale registration statement with the Securities and Exchange Commission registering the resale of the shares of Class A common stock described above.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

Use of Forward-Looking Statements

Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health In Tech's possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as "may," "will," "should," "design," "target," "aim," "hope," "expect," "could," "intend," "plan," "anticipate," "estimate," "believe," "continue," "predict," "project," "potential," "goal," or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech's actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech's control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects Health In Tech's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to Health In Tech's operations, results of operations, growth strategy and liquidity. Health In Tech undertakes no obligation to update any forward-looking statements, except as required by law.

About Health In Tech 

Health In Tech, Inc. (Nasdaq: "HIT") is an AI-enabled InsurTech platform company, which offers a marketplace that improves processes in the health insurance industry through vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, Managing General Underwriter (MGUs) and third-party administrators ("TPAs"). Health In Tech's platform serves as a marketplace for brokers, TPAs, MGUs and carriers to access self-funded health insurance for employers, providing functions including customized self-funded health plans, bindable stop-loss quotes, AI-enabled underwriting, claims administration and reporting integration.

Investor Contact:

Health In Tech Investor Relations
ir@healthintech.com

The Equity Group   
Kalle Ahl, CFA                   
T: (303) 953-9878  
kahl@theequitygroup.com

Devin Sullivan, Managing Director
dsullivan@theequitygroup.com

View original content:https://www.prnewswire.com/news-releases/health-in-tech-announces-7-0-million-private-placement-302725416.html

SOURCE Health In Tech Inc.

FAQ

What are the key terms of Health In Tech's March 25, 2026 PIPE (NASDAQ:HIT)?

Health In Tech will issue 5,600,000 Class A shares at $1.25 each, raising about $7.0 million gross. According to Health In Tech, the PIPE is expected to close on or about March 27, 2026, subject to customary closing conditions.

How does the $7.0 million PIPE affect HIT's available cash and uses?

The PIPE is expected to provide roughly $7.0 million in gross proceeds to the company. According to Health In Tech, net proceeds will fund sales distribution expansion, technology and product development, general corporate purposes, and working capital.

Who is the placement agent for Health In Tech's PIPE and what does that mean for investors?

Craig-Hallum Capital Group LLC acted as the sole placement agent for the PIPE. According to Health In Tech, the placement agent will assist in structuring and closing the transaction and fees will reduce net proceeds to the company.

When will the PIPE for HIT likely close and what conditions apply?

The PIPE is expected to close on or about March 27, 2026, but closing is not guaranteed. According to Health In Tech, the transaction remains subject to the satisfaction of customary closing conditions.

Will the shares issued in the HIT PIPE be immediately tradable by investors?

The shares are issued in a private placement and are not registered at issuance. According to Health In Tech, the company agreed to file a resale registration statement to register resale of the issued Class A common stock.

What investor risks should shareholders consider regarding the HIT PIPE announced March 25, 2026?

Key risks include dilution from issuing 5,600,000 shares and reduced net proceeds after fees. According to Health In Tech, the transaction also depends on customary closing conditions and involves forward-looking uncertainties.